Want to see SYRA full AI Analyst Report?
SYRA Stock Chart & Stats
$0.91
<$0.01(0.03%)
At close: 4:00 PM EDT
$0.91
<$0.01(0.03%)
Day’s Range― - ―
52-Week Range$0.05 - $1.15
Previous CloseN/A
Volume5.87K
Average Volume (3M)30.72K
Market Cap
$12.64M
Enterprise Value$6.66
Total Cash (Recent Filing)$2.12M
Total Debt (Recent Filing)$149.34K
Price to Earnings (P/E)101.1
Beta1.42
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding13,850,279
10 Day Avg. Volume27,552
30 Day Avg. Volume30,719
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Rapid Revenue Growth And Return To ProfitabilityThe sharp revenue expansion and return to positive earnings indicate improving demand and operating traction. If growth reflects repeatable healthcare contracts and services adoption, it could support further scale and strengthen the business over the next several quarters.
Low Current Financial LeverageConservative current leverage gives Syra more flexibility to fund operations, invest in service capacity, and absorb volatility without heavy interest burdens. The expanding asset base also suggests the operating rebound has been accompanied by balance-sheet growth.
Operating And Free Cash Flow Turned PositivePositive operating and free cash flow, broadly in line with net income, provides initial support for earnings quality and reduces immediate reliance on external funding. Sustained conversion would improve financial resilience as the company expands its healthcare offerings.
Bears Say
Profitability Remains Very ThinVery narrow margins leave limited protection against wage inflation, delivery costs, or contract pricing pressure. This makes future earnings highly sensitive to execution and revenue growth, and the company has not yet demonstrated consistently profitable annual operations.
Balance-sheet Strength Has Not Been Proven DurableThe present low-debt position is recent and follows periods of strained capitalization. That history indicates potential vulnerability if growth slows or losses return, so investors must monitor whether improved equity and leverage persist through the expansion cycle.
Expanded Equity Plan Creates Dilution RiskThe larger equity pool may help attract and retain talent, but future share issuance can dilute existing ownership and per-share earnings. For an early-stage company with thin profitability, reliance on equity compensation could become a meaningful long-term financing cost.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.05 and its highest was $1.15 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $12.64M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is Nov 18, 2026 which is in 61 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on Aug 11, 2026. The company reported $0.018 earnings per share for the quarter.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 13,850,279 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of $0.018 in its last earnings report. Following the earnings report the stock price went up 31.024%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Technical Analysis
US Physical Therapy
―
Surgery Partners
―
DocGo
―
Airsculpt Technologies
―
Concentra Group Holdings Parent, Inc.
―